| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/22/2001 | WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection |
| 03/22/2001 | DE19944604A1 Aminderivate Amine derivatives |
| 03/22/2001 | CA2387123A1 Use of thienopyrimidines |
| 03/22/2001 | CA2386559A1 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384757A1 2-imino-1,3-thiazine derivatives |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384135A1 Dipeptidyl peptidases |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2382008A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
| 03/21/2001 | EP1084243A2 Protein for regulating apoptosis |
| 03/21/2001 | EP1084146A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 03/21/2001 | EP1084129A1 Cyclic boroproline compounds |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083932A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083901A1 Efavirenz compressed tablet formulation |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1287837A Forest forg's sprawn and its application |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CN1063322C Aqueous liquid composition for eye external use as eyedrops |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204294 IL-8 receptor antagonists |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/20/2001 | US6204276 Dicarboxylic germanium complex and its therapeutic use |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204250 Immunization of infants |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | CA2206287C Aryl thioxanthines |
| 03/20/2001 | CA2071529C Diaromatic substituted anti-aids compounds |
| 03/20/2001 | CA2070169C Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018125A1 Synthetic vegetal melanins, process for their production and compositions containing thereof |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001017999A2 Amino-triazolopyridine derivatives |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017978A1 Tetrahydrobenzotriazine derivatives |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017559A1 Semaphorin modulation of immune cell migration |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017557A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | WO2001017556A1 Vaccine preparations for mucosal administration |
| 03/15/2001 | WO2001017555A2 Food grade saponins as oral adjuvants |
| 03/15/2001 | WO2001017554A1 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 03/15/2001 | WO2001017551A2 Combined vaccine compositions |
| 03/15/2001 | WO2001017550A2 Vaccine against hbv and hpv |
| 03/15/2001 | WO2001017546A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 03/15/2001 | WO2001017536A2 Novel autogenous vaccines used to obtain an immune tolerance |
| 03/15/2001 | WO2001017535A2 Enriched fraction from a porcine liver extract for treating human diseases |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2000078353A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000075113A8 Novel heterocyclic carboxamide derivatives |
| 03/15/2001 | WO2000066154A3 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 03/15/2001 | WO2000061604A3 Pharmaceutical compounds |
| 03/15/2001 | WO2000057854A3 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 03/15/2001 | DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
| 03/15/2001 | DE19940944A1 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384115A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2383998A1 Amino-triazolopyridine derivatives |
| 03/15/2001 | CA2383932A1 Synthetic vegetal melanins, process for their production and compositions containing thereof |